Precision Medicine in GU Cancers: New Challenges and New Horizons
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2281
Special Issue Editors
2. Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, 00161 Rome, Italy
Interests: hepatocellular carcinoma; bone metastasis; colorectal tumors; kidney tumors; gastric cancers
Special Issue Information
Dear Colleagues,
According to global cancer statistics, genitourinary (GU) cancers constitute the most common cancer worldwide with a high morbidity and mortality.
Nowadays, the therapeutic landscape of this disease is rapidly changing and novel treatments have shown interesting results in terms of survival and quality of life.
Unfortunately, biomarkers useful in choosing the best treatment for patients remain an unmet need, even if they can be considered as an emerging research field. So, the aim of precision medicine is to guide clinicians in the decision-making process in order to select the best treatment and to avoid toxicities.
In this Special Issue of Biomedicines, we present a series of high-quality review and research papers concerning various urologic malignancies, illustrating the current developments in precision medicine for these cancers.
- Selecting patients for immunotherapy: the role of PDL-1 in urothelial carcinoma.
- Selecting patients for bladder-sparing approach: the new frontier for precision medicine in urothelial carcinoma.
- Liquid biopsy in mRCC: what do we need to look for?
- CDK inhibitors for prostate cancer.
- Precision medicine for penile cancer: far away from target therapy?
- HER2 status in bladder cancer.
Prof. Dr. Daniele Santini
Dr. Marco Stellato
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urothelial carcinoma
- bladder cancer
- upper tract urothelial carcinoma
- renal cell carcinoma
- liquid biopsy
- prostate cancer
- CDK inhibitors
- HER2
- penile carcinoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
